C Ann Merrifield - Net Worth and Insider Trading
C Ann Merrifield Net Worth
The estimated net worth of C Ann Merrifield is at least $269,091 dollars as of 2024-09-20. C Ann Merrifield is the Director of Juniper Pharmaceuticals Inc and owns about 15,193 shares of Juniper Pharmaceuticals Inc (JNP) stock worth over $174,720. C Ann Merrifield is the Director of Flexion Therapeutics Inc and owns about 10,000 shares of Flexion Therapeutics Inc (FLXN) stock worth over $91,200. C Ann Merrifield is also the Director of Lyra Therapeutics Inc and owns about 11,328 shares of Lyra Therapeutics Inc (LYRA) stock worth over $3,172. Besides these, C Ann Merrifield also holds InVivo Therapeutics Holdings Corp (NVIVQ) . Details can be seen in C Ann Merrifield's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that C Ann Merrifield has not made any transactions after 2022-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of C Ann Merrifield
C Ann Merrifield Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, C Ann Merrifield owns 4 companies in total, including Flexion Therapeutics Inc (FLXN) , Lyra Therapeutics Inc (LYRA) , and InVivo Therapeutics Holdings Corp (NVIVQ) among others .
Click here to see the complete history of C Ann Merrifield’s form 4 insider trades.
Insider Ownership Summary of C Ann Merrifield
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FLXN | Flexion Therapeutics Inc | 2020-06-10 | director |
LYRA | Lyra Therapeutics Inc | 2022-06-10 | director |
NVIVQ | InVivo Therapeutics Holdings Corp | 2022-11-17 | director |
2018-08-14 | director |
C Ann Merrifield Latest Holdings Summary
C Ann Merrifield currently owns a total of 4 stocks. Among these stocks, C Ann Merrifield owns 15,193 shares of Juniper Pharmaceuticals Inc (JNP) as of August 26, 2016, with a value of $174,720 and a weighting of 64.93%. C Ann Merrifield owns 10,000 shares of Flexion Therapeutics Inc (FLXN) as of May 23, 2019, with a value of $91,200 and a weighting of 33.89%. C Ann Merrifield also owns 11,328 shares of Lyra Therapeutics Inc (LYRA) as of June 10, 2022, with a value of $3,172 and a weighting of 1.18%. The other 1 stocks InVivo Therapeutics Holdings Corp (NVIVQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of C Ann Merrifield
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
JNP | Juniper Pharmaceuticals Inc | 2016-08-26 | 15,193 | 11.50 | 174,720 |
FLXN | Flexion Therapeutics Inc | 2019-05-23 | 10,000 | 9.12 | 91,200 |
LYRA | Lyra Therapeutics Inc | 2022-06-10 | 11,328 | 0.28 | 3,172 |
NVIVQ | InVivo Therapeutics Holdings Corp | 2015-08-12 | 0 | 0.37 | 0 |
Holding Weightings of C Ann Merrifield
C Ann Merrifield Form 4 Trading Tracker
According to the SEC Form 4 filings, C Ann Merrifield has made a total of 0 transactions in Juniper Pharmaceuticals Inc (JNP) over the past 5 years. The most-recent trade in Juniper Pharmaceuticals Inc is the acquisition of 2,000 shares on August 26, 2016, which cost C Ann Merrifield around $11,260.
According to the SEC Form 4 filings, C Ann Merrifield has made a total of 0 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years. The most-recent trade in Flexion Therapeutics Inc is the acquisition of 8,000 shares on May 23, 2019, which cost C Ann Merrifield around $101,120.
According to the SEC Form 4 filings, C Ann Merrifield has made a total of 3 transactions in Lyra Therapeutics Inc (LYRA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Lyra Therapeutics Inc is the acquisition of 4,000 shares on June 10, 2022, which cost C Ann Merrifield around $20,200.
More details on C Ann Merrifield's insider transactions can be found in the Insider Trading History of C Ann Merrifield table.Insider Trading History of C Ann Merrifield
- 1
C Ann Merrifield Trading Performance
GuruFocus tracks the stock performance after each of C Ann Merrifield's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by C Ann Merrifield is -3.45%. GuruFocus also compares C Ann Merrifield's trading performance to market benchmark return within the same time period. The performance of stocks bought by C Ann Merrifield within 3 months outperforms 4 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how C Ann Merrifield's insider trading performs compared to the benchmark.
Performance of C Ann Merrifield
C Ann Merrifield Ownership Network
C Ann Merrifield Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
C Ann Merrifield is the director of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , General Counsel Mark S. Levine , and Chief Strategy Officer Christina Willwerth .
Flexion Therapeutics Inc (FLXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
C Ann Merrifield Mailing Address
Above is the net worth, insider trading, and ownership report for C Ann Merrifield. Currently GuruFocus does not have mailing address information for C Ann Merrifield.